Stockreport

Ampio to study nebulized Ampion as a treatment for COVID-19 [Seeking Alpha]

Ampio Pharmaceuticals, Inc.  (AMPE) 
US:NASDAQ Investor Relations: ampiopharma.com
PDF Healthcare Ampio to study nebulized Ampion as a treatment for COVID-19 Mar. 24, 2020 6:51 AM ET | Ampio Pharmaceuticals, Inc. (AMPE) Mamta Mayani Ampio Pharmaceuticals [Read more]